Eric Hedrick - 25 Feb 2022 Form 4 Insider Report for EQRx, Inc.

Signature
/s/ William Collins, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 Feb 2022
Net transactions value
$0
Form type
4
Filing time
01 Mar 2022, 16:31:30 UTC
Previous filing
20 Dec 2021
Next filing
04 Jan 2023

Quoteable Key Fact

"Eric Hedrick filed Form 4 for EQRx, Inc. on 01 Mar 2022."

Quick Takeaways

  • This page summarizes Eric Hedrick's Form 4 filing for EQRx, Inc..
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 01 Mar 2022, 16:31.

What Changed

  • Previous filing in this sequence was filed on 20 Dec 2021.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQRX Stock Option (Right to Buy) Award $0 +505,051 $0.000000 505,051 25 Feb 2022 Common Stock 505,051 $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest and become exercisable in 48 equal monthly installments commencing February 1, 2022, subject to the Reporting Person's continuous service as of each vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .